Brief: Invion Signs First Ophthalmology Collaboration Agreement With Sangmyung Innovation
19/05/2026 02:20
May 19 (Reuters) - Invion Ltd IVX.AX: SIGNS FIRST OPHTHALMOLOGY COLLABORATION AGREEMENT WITH SANGMYUNG INNOVATION SANGMYUNG TO FUND AND CONDUCT PRECLINICAL STUDIES ON PHOTOSOFT FOR WET AMD TO SUPPLY PHOTOSOFT COMPOUNDS AND RETAINS ALL PHOTOSOFT IP RIGHTS Further company coverage: IVX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Invion
See all newsAustralia's Invion rises after securing clinical trial funding arrangements
Brief: Invion Ltd Says Funding Agreements Cover Up To 85% Of Clinical Trials Costs
Brief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Australia's Invion enters ophthalmology agreement with Sangmyung Innovation
Brief: Invion Signs First Ophthalmology Collaboration Agreement With Sangmyung Innovation